The Fat Pads in Your Ears

Your eustachian tube is held closed partly by small fatty cushions. Lose enough fat and it can stay open — which makes your own voice and breathing boom inside your head. Two published cases describe exactly that after starting a GLP-1, with endoscopy confirming the cushions had thinned.^[1] Then the authors searched the FDA’s adverse event database and found the symptom reported zero times.

The mechanism, which is genuinely elegant

The eustachian tube connects the middle ear to the back of the throat and equalizes pressure. It is normally shut, opening briefly when you swallow or yawn. Part of what keeps it shut is bulk in the surrounding tissue, including fat.

When that bulk is lost, the tube can become patulous — stuck open. The result is autophony: your own voice, your breathing, sometimes your heartbeat, transmitted directly into the middle ear. People describe it as speaking into a barrel. It is not dangerous and it is genuinely unpleasant, and it is a known consequence of rapid weight loss from any cause.

In the two cases reported here, nasal endoscopy confirmed significant loss of tissue bulk in the anterior and posterior cushions of the tube. That is not an inference — someone looked.

The check that did not confirm it

Note also what dominates that list. More than half of all otologic reports are hypoacusis — reduced hearing — which is a different problem from a tube that will not close, and would not be produced by the mechanism described above.

Why publishing both halves is the right thing to do

A beautiful mechanism plus two cases is a hypothesis. The database was the test.

It would have been easy to publish the cases and the anatomy and stop. The mechanism is coherent, the endoscopy is convincing, and nobody would have checked. Reporting the zero alongside them is what makes this a useful paper rather than a persuasive one.

So the honest verdict is that this is unresolved. A specific, visible, anatomically confirmed mechanism exists in two people. Whether it happens at any meaningful rate is not answerable from a database that would probably not capture it.

One further oddity, consistent with something we have found before: the largest count of potentially tube-related events belongs to dulaglutide, at 417 — not to the drugs producing the most weight loss and attracting the most attention. If fat loss around the tube were driving this, that is not the ranking you would expect.

What to do if this is happening to you

• It is not dangerous, and it is not imaginary. Patulous eustachian tube dysfunction is a recognized condition with a recognized cause.
• It often improves as weight stabilizes, since it is driven by change rather than by a level.
• An ear, nose and throat clinician can see it — the endoscopy in these cases showed the tissue directly, so this is a symptom with an objective finding behind it.
• Say what you take. The connection is obscure enough that a clinician may not raise it, and rapid weight loss is the relevant history.

It is worth saying plainly that this is a minor problem in a field full of major ones. It appears here because a symptom with a mechanism and no reports is a good example of how to hold an uncertain finding — and because someone experiencing it is currently unlikely to find anything written about it at all.